$128.12
▼ -0.8% Today
as of Oct 23, 15:34 ET
Last 30 days
Recent Press Releases & News
Mesa Laboratories to Lay Off 40 Positions; Targets $9.3 Million Annual Cost Reduction
Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth
MESA LABS DECLARES QUARTERLY DIVIDEND
MLAB earnings at a glance
Mesa Laboratories, Inc. (MLAB) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Over its last 4 reports the stock rose the next day 1 time and fell 3, moving ±12.5% on average; after the most recent report on May 27, 2026 it moved -14.5%. MLAB beat the consensus EPS estimate in 0 of its last 3 reported quarters. The share price of $128.12 sits in the middle of its 52-week range.
Overview
52-week range
$70
$144
78% of range
Avg surprise (last 3)
-16.4%
Avg reaction (last 4)
-11.7%
25% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.49 | — | — | — | — | financials |
| Wed May 27, 2026 | Mar/2026 | $1.53 | $1.78 | -14.0% | -7.3% | -14.5% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $0.65 | — | — | — | — | financials |
| Thu Nov 6, 2025 | Sep/2025 | $1.22 | — | — | — | +1.5% | earnings |
| Tue Aug 5, 2025 | Jun/2025 | $1.62 | $1.83 | -11.5% | — | -24.9% | earnings |
| Wed May 28, 2025 | Mar/2025 | $1.65 | $2.16 | -23.6% | — | -8.9% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-0.31 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $0.63 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.62 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $0.39 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.23 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.10 | — | — | — | — | financials |
| Sat Dec 31, 2022 | Dec 2022 | $0.08 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Nov 5, 2026 | Sep/2026 | OTHER | — | $1.22 |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $60M | — | $65M | $61M | $60M | — | $63M | $58M |
| Cost of revenue | $21M | — | $23M | $23M | $23M | — | $23M | $22M |
| Gross profit | $39M | — | $42M | $37M | $37M | — | $40M | $35M |
| Operating income | $7M | — | $8M | $5M | $3M | — | $6M | $4M |
| Net income | $3M | — | $4M | $2M | $5M | — | $-2M | $3M |
| EPS (diluted) | $0.49 | — | $0.65 | $0.45 | $0.85 | — | $-0.31 | $0.63 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $31M | $27M | $29M | $20M | $21M | $27M | $27M | $24M |
| Inventory | $27M | $26M | $27M | $28M | $28M | $25M | $25M | $30M |
| Total current assets | $103M | $106M | $106M | $97M | $98M | $103M | $103M | $108M |
| Total assets | $419M | $428M | $435M | $430M | $436M | $433M | $433M | $454M |
| Long-term debt | $66M | — | $68M | $69M | $70M | — | $72M | $73M |
| Total liabilities | $230M | $242M | $248M | $252M | $263M | $274M | $274M | $293M |
| Total equity | $189M | $186M | $187M | $178M | $172M | $160M | $155M | $161M |
Implied volatility — last 90 days
No IV snapshots yet for MLAB.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
MLAB earnings FAQ
When is MLAB's next earnings date?
Mesa Laboratories, Inc. is expected to report on November 5, 2026.
How does MLAB stock usually react to earnings?
Across the last 4 reports the average next-day move was ±12.5%, up 1 times and down 3 times.